https://builtin.com/job/senior-manager-digital-marketing-technology-lead/8317236
Senior Manager, Digital Marketing Technology Lead - Nuvation Bio | Built In
Nuvation Bio is hiring for a Remote Senior Manager, Digital Marketing Technology Lead in State Road, IL, USA. Find more details about the job and how to apply...
digital marketing technologysenior managernuvation bioleadbuilt
https://investingnews.com/eisai-and-nuvation-bio-announce-marketing-authorisation-application-for-taletrectinib-for-the-treatment-of-advanced-ros1-positive-non-small-cell-lung-cancer-validated-by-the-european-medicines-agency/
Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the...
Mar 26, 2026 - The Marketing Authorisation Application (MAA) has been validated and accepted for full approval consideration with a standard review timelineAdditional filings...
nuvation biomarketing authorisationeisaiannounce
https://www.macrotrends.net/stocks/charts/NUVB/nuvation-bio/pre-tax-profit-margin
Nuvation Bio Pre-Tax Profit Margin 2020-2026 | NUVB | MacroTrends
Nuvation Bio pre-tax profit margin from 2020 to 2026. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
pre tax profitnuvation biomargin20202026
https://www.businesswire.com/news/home/20250402120689/en/Nuvation-Bio-to-Present-at-the-Jones-Healthcare-and-Technology-Innovation-Conference
Nuvation Bio to Present at the Jones Healthcare and Technology Innovation Conference
Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M....
healthcare and technologynuvation biothe jones
https://www.nasdaq.com/market-activity/stocks/nuvb/institutional-holdings
Nuvation Bio Inc. Class A Common Stock (NUVB) Institutional Holdings | Nasdaq
Find the latest institutional holdings data for Nuvation Bio Inc. Class A Common Stock (NUVB) including shareholders, ownership summaries, and holding...
class a common stocknuvation bioinstitutional holdingsinc
https://www.home.saxo/pl-pl/markets/stocks/nuvb-xnys
Nuvation Bio Inc. akcja | Saxo Bank
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates.
nuvation bioincakcjasaxobank
https://www.benzinga.com/quote/nuvb
Nuvation Bio (NUVB) Stock Price, Quote, News & History | Benzinga
Get real-time Nuvation Bio (NUVB) stock price, charts, news, and analyst ratings on Benzinga. Access forecasts, historical data, and expert insights to inform...
stock price quotenuvation bionews historynuvbbenzinga
https://www.nasdaq.com/market-activity/stocks/nuvb/historical-nocp
Nuvation Bio Inc. Class A Common Stock (NUVB) Historical NOCP | Nasdaq
Get the latest insights on Nuvation Bio Inc. Class A Common Stock (NUVB) historical NOCP to help you in your trading and investing decisions.
class a common stocknuvation biohistorical nocpinc
https://www.businesswire.com/news/home/20250507914974/en/Nuvation-Bio-Reports-First-Quarter-2025-Financial-Results-and-Provides-Business-Update
Nuvation Bio Reports First Quarter 2025 Financial Results and Provides Business Update
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company tackling some of the toughest challenges in cancer treatment, today reported financial results for ...
nuvation biofirst quarter
https://www.biospace.com/nuvation-bio-announces-fda-clearance-of-investigational-new-drug-application-for-nuv-422-for-the-treatment-of-advanced-breast-cancer
Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-422 for the...
Dec 8, 2021 - Nuvation Bio Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to evaluate...